FindMyKOL
Clinical trialNCT06122896RecruitingEarly phase 1Interventional

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

SponsorDana-Farber Cancer InstituteEnrollment5,000PDACPDAC - Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Neoplasm
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this research is to see if adding blood-based tests and symptom review to standard-of-care pancreatic cancer screening procedures can identify cancer early among individuals with increased risk.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

    Matthew Yurgelun, MD
    Not, yet, recruiting
  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

    Matthew B Yurgelun, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Nov 2023
Primary completion
31 Oct 2040
Completion
31 Oct 2041
Last update posted
29 May 2026
Registered enrollment
5,000
Registry id
NCT06122896
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.